LCMT2
Basic information
Region (hg38): 15:43323649-43330582
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LCMT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 60 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 60 | 4 | 0 |
Variants in LCMT2
This is a list of pathogenic ClinVar variants found in the LCMT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-43328482-A-G | not specified | Uncertain significance (Apr 17, 2024) | ||
15-43328509-C-G | not specified | Uncertain significance (Jan 11, 2023) | ||
15-43328619-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
15-43328670-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
15-43328788-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
15-43328791-G-A | not specified | Uncertain significance (May 24, 2023) | ||
15-43328833-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
15-43328848-T-A | not specified | Uncertain significance (Oct 26, 2022) | ||
15-43328859-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
15-43328869-T-C | not specified | Uncertain significance (Mar 01, 2023) | ||
15-43328899-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
15-43328931-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
15-43328940-C-T | not specified | Likely benign (Dec 11, 2023) | ||
15-43328947-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
15-43328983-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
15-43329046-G-T | not specified | Uncertain significance (Nov 22, 2023) | ||
15-43329063-G-C | not specified | Uncertain significance (Jul 31, 2023) | ||
15-43329106-G-C | not specified | Uncertain significance (Jun 07, 2024) | ||
15-43329111-T-G | not specified | Uncertain significance (May 29, 2024) | ||
15-43329145-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
15-43329202-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
15-43329316-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
15-43329326-C-G | not specified | Uncertain significance (Mar 12, 2024) | ||
15-43329396-A-G | not specified | Uncertain significance (May 15, 2023) | ||
15-43329403-C-T | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LCMT2 | protein_coding | protein_coding | ENST00000305641 | 1 | 2830 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.63e-15 | 0.00925 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.97 | 499 | 390 | 1.28 | 0.0000193 | 4396 |
Missense in Polyphen | 150 | 117.95 | 1.2717 | 1367 | ||
Synonymous | -1.40 | 189 | 166 | 1.14 | 0.00000815 | 1497 |
Loss of Function | -0.138 | 22 | 21.3 | 1.03 | 0.00000113 | 225 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA (By similarity). May methylate the carboxyl group of leucine residues to form alpha- leucine ester residues. {ECO:0000250}.;
- Pathway
- Synthesis of wybutosine at G37 of tRNA(Phe);tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA;wybutosine biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.925
- rvis_EVS
- -0.04
- rvis_percentile_EVS
- 50.5
Haploinsufficiency Scores
- pHI
- 0.0779
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.538
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.719
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lcmt2
- Phenotype
Gene ontology
- Biological process
- tRNA modification;C-terminal protein methylation;tRNA methylation;wybutosine biosynthetic process
- Cellular component
- cytoplasm
- Molecular function
- protein binding;tRNA methyltransferase activity;protein C-terminal leucine carboxyl O-methyltransferase activity